Gene · 2739
NIH grants848
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 848
Download this page as JSON| Grant | Title | GLO1 papers | Newest fiscal year |
|---|---|---|---|
| R00GM135537 | Role of pseudouridines in pre-mRNA processing | 1 | 2024 |
| R00NS116679 | Biophysical Determinants of Physiological and Pathological alpha-Synuclein Membrane Interactions | 1 | 2024 |
| R01AG015819 | Risk Factors, Pathology, and Clinical Expressions of AD | 1 | 2024 |
| R01AG066831 | Elucidating changes in astrocyte subpopulations associated with resistance to Alzheimers Disease pathology in multi-ethnic cohorts | 1 | 2024 |
| R01CA245294 | 3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer | 1 | 2024 |
| R01DA048638 | Genetic and hormonal contributions to sex differences in vulnerability to drug use | 1 | 2024 |
| R01DK102960 | 'Metabolically Activated' Macrophages in Obesity and Insulin Resistance | 1 | 2024 |
| R01DK128937 | Mechanistic study of Small-molecular Therapy in diabetic Wound Healing | 1 | 2024 |
| R01ES031463 | Redox and Protein Homeostasis in Arsenic Tumorigenicity | 1 | 2024 |
| R01HL164306 | Diastolic Heart Failure in HIV-1 infection | 1 | 2024 |
| R01NS072129 | Mechanisms of synapse formation and axon termination in C. elegans | 1 | 2024 |
| R01NS117137 | Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models | 1 | 2024 |
| R15NS116478 | Glial Cells and Polyamine Signaling in the Central Nervous System | 1 | 2024 |
| R21AG081916 | Exploring regulatory mechanisms of glyoxalase-1 | 1 | 2024 |
| R21CA282612 | Identification of metabolic adducts associated with prostate cancer progression in African American men Supplement | 1 | 2024 |
| R24OD023041 | Enhancing the C. elegans animal resource through genome editing | 1 | 2024 |
| T32AT004094 | Botanical Approaches to Combat Metabolic Syndrome | 1 | 2024 |
| T32DK067872 | Research Training in Gastroenterology and Hepatology | 1 | 2024 |
| T42OH008434 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 1 | 2024 |
| U01AG032984 | Alzheimer's Disease Genetics Consortium | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/grants?page=8